dc.date.accessioned2021-05-18T21:44:16Z
dc.date.available2021-05-18T21:44:16Z
dc.date.created2021-05-18T21:44:16Z
dc.date.issued2021
dc.identifierhttps://hdl.handle.net/20.500.12866/9389
dc.identifierhttps://doi.org/10.1016/j.jormas.2021.03.011
dc.description.abstractNumerous randomized clinical trials have evaluated the efficacy of preoperative or postoperative administration of anti-inflammatory drugs alone or in combination with analgesics to control pain, inflammation, and trismus after third molar surgery. Moreover, this surgical procedure can trigger mixed pain (overlapping symptoms of nociceptive pain and neuropathic pain), which was one of the main reasons to evaluate the efficacy of an anti inflammatory drug such as diclofenac (for nociceptive pain) associated with vitamins B1, B6, and B12 (for neuropathic pain)
dc.languageeng
dc.publisherElsevier
dc.relationJournal of Stomatology, Oral and Maxillofacial Surgery
dc.relation2468-7855
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectEvidence-based dentistry
dc.subjectMolar
dc.subjectPreemptive analgesia
dc.subjectThird
dc.titleNeed for randomized clinical Trials on the management of pain, inflammation and trismus in surgery of impacted third molars
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución